193 related articles for article (PubMed ID: 31416538)
1. Computational models for predicting anticancer drug efficacy: A multi linear regression analysis based on molecular, cellular and clinical data of oral squamous cell carcinoma cohort.
Robert BM; Brindha GR; Santhi B; Kanimozhi G; Prasad NR
Comput Methods Programs Biomed; 2019 Sep; 178():105-112. PubMed ID: 31416538
[TBL] [Abstract][Full Text] [Related]
2. Precise prediction of multiple anticancer drug efficacy using multi target regression and support vector regression analysis.
Brindha GR; Rishiikeshwer BS; Santhi B; Nakendraprasath K; Manikandan R; Gandomi AH
Comput Methods Programs Biomed; 2022 Sep; 224():107027. PubMed ID: 35914385
[TBL] [Abstract][Full Text] [Related]
3. Predicting Tumor Sensitivity to Chemotherapeutic Drugs in Oral Squamous Cell Carcinoma Patients.
Robert BM; Dakshinamoorthy M; Ganapathyagraharam Ramamoorthy B; Dhandapani M; Thangaiyan R; Muthusamy G; Nirmal RM; Prasad NR
Sci Rep; 2018 Oct; 8(1):15545. PubMed ID: 30341378
[TBL] [Abstract][Full Text] [Related]
4. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
5. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
[TBL] [Abstract][Full Text] [Related]
6. ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy.
Fu G; Somasundaram RT; Jessa F; Srivastava G; MacMillan C; Witterick I; Walfish PG; Ralhan R
Oncotarget; 2016 Mar; 7(13):17162-81. PubMed ID: 26934445
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database.
Liu R; Li X; Zhang W; Zhou HH
PLoS One; 2015; 10(8):e0135784. PubMed ID: 26305568
[TBL] [Abstract][Full Text] [Related]
8. A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy.
Wang ZQ; Liu K; Huo ZJ; Li XC; Wang M; Liu P; Pang B; Wang SJ
J Nanobiotechnology; 2015 Oct; 13():63. PubMed ID: 26427800
[TBL] [Abstract][Full Text] [Related]
9. The Predictive Model of Oral Squamous Cell Survival Carcinoma: A Methodology of Validation.
Ahmad WMAW; Yaqoob MA; Noor NFM; Ghazali FMM; Rahman NA; Tang L; Aleng NA; Alam MK
Biomed Res Int; 2021; 2021():5436894. PubMed ID: 34904115
[TBL] [Abstract][Full Text] [Related]
10. Acetylshikonin inhibits growth of oral squamous cell carcinoma by inducing apoptosis.
Kim DJ; Lee JH; Park HR; Choi YW
Arch Oral Biol; 2016 Oct; 70():149-157. PubMed ID: 27371806
[TBL] [Abstract][Full Text] [Related]
11. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
12. Predicting blood β-hydroxybutyrate using milk Fourier transform infrared spectrum, milk composition, and producer-reported variables with multiple linear regression, partial least squares regression, and artificial neural network.
Pralle RS; Weigel KW; White HM
J Dairy Sci; 2018 May; 101(5):4378-4387. PubMed ID: 29477523
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
[TBL] [Abstract][Full Text] [Related]
14. Computational identification of multi-omic correlates of anticancer therapeutic response.
Stetson LC; Pearl T; Chen Y; Barnholtz-Sloan JS
BMC Genomics; 2014; 15 Suppl 7(Suppl 7):S2. PubMed ID: 25573145
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis.
Ahn MY; Kwon SM; Cheong HH; Park JH; Lee J; Min SK; Ahn SG; Yoon JH
J Oral Pathol Med; 2012 Aug; 41(7):540-6. PubMed ID: 22577802
[TBL] [Abstract][Full Text] [Related]
16. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
Wang L; Li X; Zhang L; Gao Q
BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
[TBL] [Abstract][Full Text] [Related]
17. Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Roy K; Pratim Roy P
Eur J Med Chem; 2009 Jul; 44(7):2913-22. PubMed ID: 19128860
[TBL] [Abstract][Full Text] [Related]
18. Isomahanine induces endoplasmic reticulum stress and simultaneously triggers p38 MAPK-mediated apoptosis and autophagy in multidrug-resistant human oral squamous cell carcinoma cells.
Utaipan T; Athipornchai A; Suksamrarn A; Chunsrivirot S; Chunglok W
Oncol Rep; 2017 Feb; 37(2):1243-1252. PubMed ID: 28075474
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro.
Gao L; Dong J; Zhang N; Le Z; Ren W; Li S; Li F; Song J; Wang Q; Dou Z; Park SY; Zhi K
Anticancer Agents Med Chem; 2019; 19(2):248-255. PubMed ID: 30378503
[TBL] [Abstract][Full Text] [Related]
20. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
